Literature DB >> 24517636

Evaluation of diclofenac prodrugs for enhancing transdermal delivery.

Shabbir Lobo1, Henan Li, Nashid Farhan, Guang Yan.   

Abstract

UNLABELLED: Abstract Objective: The purpose of this study was to evaluate the approach of using diclofenac acid (DA) prodrugs for enhancing transdermal delivery.
METHODS: Methanol diclofenac ester (MD), ethylene glycol diclofenac ester (ED), glycerol diclofenac ester (GD) and 1,3-propylene glycol diclofenac ester (PD) were synthesized and evaluated for their physicochemical properties such as solubilities, octanol/water partition coefficients, stratum corneum/water partition coefficients, hydrolysis rates and bioconversion rates. In vitro fluxes across human epidermal membrane (HEM) in the Franz diffusion cell were determined on DA-, MD-, ED-, GD- and PD-saturated aqueous solutions.
RESULTS: The formation of GD and ED led to the prodrugs with higher aqueous solubilities and lower partition coefficients than those of the parent drug. Prodrugs with improved aqueous solubility showed better fluxes across HEM in aqueous solution than that of the parent drug, with GD showing the highest aqueous solubility and also the highest flux. There is a linear relationship between the aqueous solubility and flux for DA, ED and PD, but GD and MD deviated from the linear line.
CONCLUSION: Diclofenac prodrugs with improved hydrophilicity than the parent drug could be utilized for enhancing transdermal diclofenac delivery.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24517636      PMCID: PMC4772728          DOI: 10.3109/03639045.2013.767828

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  18 in total

Review 1.  Synthesis and anti-phlogistic potency of some new non-proteinogenic amino acid conjugates of "Diclofenac".

Authors:  M H Abo-Ghalia; A M Shalaby; W I el-Eraqi; H M Awad
Journal:  Amino Acids       Date:  1999       Impact factor: 3.520

2.  Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials.

Authors:  Jinying Lin; Weiya Zhang; Adrian Jones; Michael Doherty
Journal:  BMJ       Date:  2004-07-30

3.  In vitro evaluation of acyloxyalkyl esters as dermal prodrugs of ketoprofen and naproxen.

Authors:  J Rautio; H Taipale; J Gynther; J Vepsalainen; T Nevalainen; T Jarvinen
Journal:  J Pharm Sci       Date:  1998-12       Impact factor: 3.534

4.  In vitro and in vivo evaluation of polyoxyethylene esters as dermal prodrugs of ketoprofen, naproxen and diclofenac.

Authors:  F P Bonina; C Puglia; T Barbuzzi; P de Caprariis; F Palagiano; M G Rimoli; A Saija
Journal:  Eur J Pharm Sci       Date:  2001-09       Impact factor: 4.384

5.  In vitro/in vivo correlation of transdermal naltrexone prodrugs in hairless guinea pigs.

Authors:  Satyanarayana Valiveti; Kalpana S Paudel; Dana C Hammell; Mohamed O Hamad; Jianhong Chen; Peter A Crooks; Audra L Stinchcomb
Journal:  Pharm Res       Date:  2005-06-08       Impact factor: 4.200

6.  Synthesis and evaluation of Ketorolac ester prodrugs for transdermal delivery.

Authors:  Hea-Jeong Doh; Won-Jea Cho; Chul-Soon Yong; Han-Gon Choi; Jung Sun Kim; Chi-Ho Lee; Dae-Duk Kim
Journal:  J Pharm Sci       Date:  2003-05       Impact factor: 3.534

7.  Mechanistic study of alkyl azacycloheptanones as skin permeation enhancers by permeation and partition experiments with hairless mouse skin.

Authors:  Ning He; S Kevin Li; T Marjukka Suhonen; Kevin S Warner; William I Higuchi
Journal:  J Pharm Sci       Date:  2003-02       Impact factor: 3.534

8.  The effect of temperature upon the permeation of polar and ionic solutes through human epidermal membrane.

Authors:  K D Peck; A H Ghanem; W I Higuchi
Journal:  J Pharm Sci       Date:  1995-08       Impact factor: 3.534

9.  Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease.

Authors:  J Radermacher; D Jentsch; M A Scholl; T Lustinetz; J C Frölich
Journal:  Br J Clin Pharmacol       Date:  1991-05       Impact factor: 4.335

Review 10.  Nonsteroidal anti-inflammatory drug-related gastrointestinal toxicity: definitions and epidemiology.

Authors:  D McCarthy
Journal:  Am J Med       Date:  1998-11-02       Impact factor: 4.965

View more
  5 in total

1.  Potential of Piperazinylalkylester Prodrugs of 6-Methoxy-2-Naphthylacetic Acid (6-MNA) for Percutaneous Drug Delivery.

Authors:  Vijay Pawar; Rushabh Thosani; Ashish Kanhed; Rajani Giridhar; Mange Ram Yadav
Journal:  AAPS PharmSciTech       Date:  2014-11-06       Impact factor: 3.246

Review 2.  The Prodrug Approach: A Successful Tool for Improving Drug Solubility.

Authors:  Daniela Hartmann Jornada; Guilherme Felipe dos Santos Fernandes; Diego Eidy Chiba; Thais Regina Ferreira de Melo; Jean Leandro dos Santos; Man Chin Chung
Journal:  Molecules       Date:  2015-12-29       Impact factor: 4.411

Review 3.  Prodrug strategies for enhancing the percutaneous absorption of drugs.

Authors:  David D N'Da
Journal:  Molecules       Date:  2014-12-12       Impact factor: 4.411

4.  Permeation measurement of gestodene for some biodegradable materials using Franz diffusion cells.

Authors:  Danhua Liu; Chong Zhang; Xiaowei Zhang; Zhu Zhen; Ping Wang; Jianxin Li; Dongxu Yi; Ying Jin; Dan Yang
Journal:  Saudi Pharm J       Date:  2015-01-12       Impact factor: 4.330

5.  Cocrystal construction between the ethyl ester with parent drug of diclofenac: structural, stability, and anti-inflammatory study.

Authors:  Ilma Nugrahani; Dwi Utami; Yuda Prasetya Nugraha; Hidehiro Uekusa; Rahel Hasianna; Aisyah Amalia Darusman
Journal:  Heliyon       Date:  2019-12-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.